Off-Patent Reports

Off-Patent Reports

Off-Patent Reports

Multi-Client Reports Detailing New Opportunities in
Generic/Off-Patent Agrochemicals


EMR’s reports are focused at identifying opportunities in the agrochemical industry.

Our latest report:

"New Off-Patent/Generic Agrochemicals – Post 2017"

A new report, the 9th in the series, on the market for off-patent/generic agrochemicals with patents expiring between 2017 and 2022.

The report includes blockbuster products such as chlorantraniliprole, thiencarbazone-methyl (mixed with many other active ingredients) and niche products such as the rice fungicide isotianil.


To purchase this report please fill in the purchase order found in the brochure and email back to us.




Our previous reports specialise in the identification of agrochemical active ingredients that are approaching patent expiry in the near-term (next 4 years). The nine reports titled “New Off-Patent/Generic Agrochemicals - Post 2000, 2002, 2005, 2007, 2009, 2011, 2013, 2015 and 2017” cover over 200 major active ingredients with significant commercial opportunities for generic manufacturers.





In 2016 EMR published "What Happens in the Market After an Agrochemical Patent Expires?" This was the culmination of 16 years of scrutinising patent expiry of agrochemical active ingredients (a.is.), this new report analyses quantitative and qualitative data of 88 a.is. with patent expiry dates spanning 2000 to 2017.


With a market value of US$ 21 billion, these 88 a.is. represent 36% of the US$ 60 billion crop protection market. Most analysts suggest that generic products have captured 25-30% of the total crop protection market, yet, for these 88 a.is., generic companies only have on average a 11% market share – why is this? Each a.i. is explored to determine the extent of generic sector activity post expiry of its patent.


For more detailed information please download our brochure.

“Enigma’s series of reports on 'New Off-Patent/Generic Agrochemicals' have been of great value in helping us map the future of our development in the growing off-patent sector”

Christina Cheng, Senior Business Analyst, Nufarm Limited, Australia

 

Choose a report:

There are no products in this collection.